XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://finanza.primeconsult.it/per-capire-lefficacia-della-vaccinazione-anti-covid-bisogna-guardare-verso-israele/60%Monthly2021-01-30 06:00
https://finanza.primeconsult.it/anche-il-vaccino-astrazeneca-ha-ricevuto-il-via-libera-in-europa/60%Monthly2021-01-29 15:24
https://finanza.primeconsult.it/anche-il-vaccino-anti-covid-di-johnson-johnson-sembra-funzionare-con-una-sola-dose/60%Monthly2021-01-29 14:20
https://finanza.primeconsult.it/dovremmo-cominciare-a-indossare-due-mascherine/60%Monthly2021-01-29 14:12
https://finanza.primeconsult.it/e-stato-reso-pubblico-il-contratto-delleuropa-con-astrazeneca-per-il-vaccino-anti-covid/60%Monthly2021-01-29 14:01
https://finanza.primeconsult.it/i-primi-risultati-del-vaccino-covid-19-di-novavax-sono-promettenti/60%Monthly2021-01-29 11:29
https://finanza.primeconsult.it/cosa-ci-dicono-gli-ultimi-numeri-sul-coronavirus-in-italia/60%Monthly2021-01-29 06:00
https://finanza.primeconsult.it/perche-e-il-momento-di-parlare-di-neuro-privacy/60%Monthly2021-01-29 06:00
https://finanza.primeconsult.it/la-lattoferrina-e-davvero-efficace-contro-il-coronavirus-parte-uno-studio-a-biella/60%Monthly2021-01-28 06:00
https://finanza.primeconsult.it/perche-la-commissione-europea-se-la-sta-prendendo-con-astrazeneca/60%Monthly2021-01-27 13:10
https://finanza.primeconsult.it/laccademia-online-non-e-un-destino/60%Monthly2021-01-27 12:09
https://finanza.primeconsult.it/la-colchicina-potrebbe-essere-il-primo-farmaco-a-ridurre-le-ospedalizzazioni-per-covid-19/60%Monthly2021-01-27 11:15
https://finanza.primeconsult.it/tutte-le-criticita-delle-clausole-dei-contratti-sui-vaccini-anti-covid/60%Monthly2021-01-27 11:02
https://finanza.primeconsult.it/stiamo-davvero-usando-la-sesta-dose-del-vaccino-pfizer/60%Monthly2021-01-26 06:00
https://finanza.primeconsult.it/qualche-novita-sulle-varianti-del-coronavirus/60%Monthly2021-01-25 13:31
https://finanza.primeconsult.it/ecco-lerrore-nel-calcolo-di-rt-che-ha-portato-la-lombardia-in-zona-rossa/60%Monthly2021-01-25 10:21
https://finanza.primeconsult.it/a-che-punto-siamo-con-lintelligenza-artificiale-generale/60%Monthly2021-01-25 06:00
https://finanza.primeconsult.it/coronavirus-5-domande-importanti-a-cui-non-sappiamo-ancora-rispondere/60%Monthly2021-01-23 06:00
https://finanza.primeconsult.it/coronavirus-nei-primi-mesi-del-2020-circolavano-in-lombardia-7-varianti/60%Monthly2021-01-22 17:51
https://finanza.primeconsult.it/ecco-il-piano-di-joe-biden-contro-il-coronavirus/60%Monthly2021-01-22 11:28
https://finanza.primeconsult.it/la-lingua-da-covid-e-un-nuovo-possibile-sintomo-del-coronavirus/60%Monthly2021-01-22 11:03
https://finanza.primeconsult.it/si-stanno-studiando-anche-altri-anticorpi-monoclonali-contro-covid-19/60%Monthly2021-01-22 06:00
https://finanza.primeconsult.it/moderna-lavora-anche-a-un-vaccino-a-mrna-contro-hiv/60%Monthly2021-01-21 14:35
https://finanza.primeconsult.it/ce-qualcosa-che-non-funziona-nei-dati-italiani-sui-tamponi/60%Monthly2021-01-21 12:29
https://finanza.primeconsult.it/le-aragoste-sono-diventate-un-modello-per-la-stampa-3d/60%Monthly2021-01-21 11:26
https://finanza.primeconsult.it/il-vaccino-di-pfizer-sembra-efficace-anche-contro-la-variante-inglese/60%Monthly2021-01-21 11:14
https://finanza.primeconsult.it/quando-potro-vaccinarmi/60%Monthly2021-01-21 06:00
https://finanza.primeconsult.it/come-si-affrontano-le-nuove-varianti-del-coronavirus/60%Monthly2021-01-20 06:00
https://finanza.primeconsult.it/limmunita-naturale-al-coronavirus-puo-durare-per-almeno-sei-mesi-se-non-di-piu/60%Monthly2021-01-19 13:34
https://finanza.primeconsult.it/leonardo-drone-contest-2021-si-scaldano-i-motori-per-la-seconda-sfida/60%Monthly2021-01-19 11:10
https://finanza.primeconsult.it/coronavirus-cosa-sappiamo-sulla-variante-scoperta-in-brasile/60%Monthly2021-01-19 09:00
https://finanza.primeconsult.it/cosa-possono-e-non-possono-dirci-i-test-genetici-sul-rischio-covid-19/60%Monthly2021-01-19 06:00
https://finanza.primeconsult.it/il-primo-banco-di-pesci-robot/60%Monthly2021-01-18 10:33
https://finanza.primeconsult.it/come-joe-biden-vuole-rilanciare-il-settore-tech/60%Monthly2021-01-18 06:00
https://finanza.primeconsult.it/una-lampada-led-a-luce-blu-puo-bastare-a-sconfiggere-il-nuovo-coronavirus/60%Monthly2021-01-18 06:00
https://finanza.primeconsult.it/coronavirus-a-quando-i-vaccini-anche-per-i-bambini-e-gli-adolescenti/60%Monthly2021-01-17 06:00
https://finanza.primeconsult.it/chi-rischia-di-soffrire-di-long-covid/60%Monthly2021-01-16 06:00
https://finanza.primeconsult.it/attenzione-a-dire-che-il-tasso-di-positivita-e-crollato/60%Monthly2021-01-15 19:22
https://finanza.primeconsult.it/cosa-ce-da-sapere-sulla-sesta-dose-del-vaccino-pfizer-biontech/60%Monthly2021-01-15 11:29
https://finanza.primeconsult.it/ecco-come-una-regione-finisce-in-zona-bianca-gialla-arancione-e-rossa/60%Monthly2021-01-15 06:00
https://finanza.primeconsult.it/con-la-saliva-si-potrebbe-prevedere-la-gravita-di-covid-19/60%Monthly2021-01-14 13:38
https://finanza.primeconsult.it/il-vaccino-cinese-coronavac-sarebbe-efficace-soltanto-al-504/60%Monthly2021-01-14 10:09
https://finanza.primeconsult.it/dobbiamo-avere-paura-delle-nuove-varianti-del-coronavirus/60%Monthly2021-01-14 06:00
https://finanza.primeconsult.it/cosa-faranno-gli-esperti-dellorganizzazione-mondiale-della-sanita-a-wuhan/60%Monthly2021-01-13 11:28
https://finanza.primeconsult.it/e-passato-un-anno-dalla-comparsa-di-polmoniti-misteriose-in-cina/60%Monthly2021-01-13 06:00
https://finanza.primeconsult.it/assegnati-i-premi-shkreli-2020-ai-peggiori-nella-sanita-usa-ce-anche-moderna/60%Monthly2021-01-12 14:52
https://finanza.primeconsult.it/ces-2021-la-pattuglia-delle-startup-italiane/60%Monthly2021-01-12 14:13
https://finanza.primeconsult.it/per-trattare-covid-19-grave-si-potrebbero-usare-le-staminali/60%Monthly2021-01-12 06:00
https://finanza.primeconsult.it/forse-abbiamo-trovato-il-paziente-1-italiano-una-donna-era-positiva-al-coronavirus-a-novembre-2019/60%Monthly2021-01-11 13:59
https://finanza.primeconsult.it/didattica-a-distanza-un-fallimento-organizzativo-ma-anche-umano/60%Monthly2021-01-11 11:55
https://finanza.primeconsult.it/in-campania-sono-state-somministrate-piu-dosi-di-vaccino-anti-covid-di-quelle-ricevute-come-possibile/60%Monthly2021-01-11 10:19
https://finanza.primeconsult.it/perche-i-vaccini-a-mrna-possono-essere-cambiati-rapidamente-in-caso-di-mutazioni/60%Monthly2021-01-11 06:00
https://finanza.primeconsult.it/vaccino-covid-quando-bisogna-fare-la-seconda-dose/60%Monthly2021-01-09 06:00
https://finanza.primeconsult.it/quanto-e-efficace-il-vaccino-anti-covid-cinese-coronavac/60%Monthly2021-01-08 14:30
https://finanza.primeconsult.it/coronavirus-in-italia-per-poter-riaprire-non-basta-un-rt-basso/60%Monthly2021-01-08 10:58
https://finanza.primeconsult.it/covid-19-potrebbe-causare-danni-cerebrali-anche-se-il-virus-non-e-nel-cervello/60%Monthly2021-01-08 09:00
https://finanza.primeconsult.it/come-cambiato-il-fenomeno-della-tossicodipendenza-dopo-gli-anni-raccontati-in-sanpa/60%Monthly2021-01-08 06:00
https://finanza.primeconsult.it/coronavirus-le-varianti-scoperte-nel-regno-unito-e-in-sudafrica-riducono-lefficacia-dei-vaccini/60%Monthly2021-01-07 11:53
https://finanza.primeconsult.it/come-la-scienza-studia-lansia-e-la-depressione-indotte-dalla-poverta/60%Monthly2021-01-07 09:30
https://finanza.primeconsult.it/come-stanno-andando-le-vaccinazioni-contro-il-coronavirus-in-italia/60%Monthly2021-01-07 06:00
https://finanza.primeconsult.it/quanto-ci-vuole-perche-il-vaccino-contro-il-coronavirus-faccia-effetto/60%Monthly2021-01-06 06:00
https://finanza.primeconsult.it/che-cosa-sappiamo-della-variante-sudafricana-di-sars-cov-2/60%Monthly2021-01-05 13:31
https://finanza.primeconsult.it/cosa-possiamo-dire-sul-vaccino-italiano-spallanzani-reithera/60%Monthly2021-01-05 13:23
https://finanza.primeconsult.it/anche-la-pelle-ha-il-suo-microbioma/60%Monthly2021-01-05 09:31
https://finanza.primeconsult.it/che-fine-ha-fatto-il-vaccino-di-oxford-e-astrazeneca/60%Monthly2021-01-04 11:18
https://finanza.primeconsult.it/dallemocromo-si-puo-prevedere-la-gravita-di-covid-19/60%Monthly2021-01-02 06:00
https://finanza.primeconsult.it/50-persone-da-tenere-docchio-nel-2021/60%Monthly2021-01-01 06:16
https://finanza.primeconsult.it/il-coronavirus-potrebbe-infilarsi-anche-nei-nostri-cromosomi/60%Monthly2021-01-01 06:00